What We Do
Cannabis Science, Inc. is at the forefront of cannabinoid research for the development of cannabis-based medicines to satisfy unmet medical needs. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.
Read More +
Research & Development
Our pursuit of knowledge is done creatively and diligently. Our team of bright minds is always at work to undertake groundbreaking research, and use it to devise new, innovative, and exciting projects, such as medications that can save lives and change a patient’s way of life for the better, and expanding globally so that our positive influence reaches across borders.
Read More +
The Science of Cannabinoids
Cannabinoids have an extensive history dating back thousands of years, and currently there are thousands of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The endocannabinoid system possessed by all vertebrates regulates all body systems and maintains homeostasis.
Read More +
Pipeline
See what Cannabis Science has in the works and their progress. These programs will change the lives of many people of all ages, shapes, and sizes, with a variety of illnesses that cannabinoid-based medications can target. These illnesses include cancer, HIV/AIDS, arthritis, chronic pain, and a myriad of others. Click here to see what’s coming down the pipeline!
Read More +
Cannabis Science is the first publicly traded cannabinoid company on the market, whose symbol is CBIS, and is the only publicly traded company in existence that is involved in cannabinoid-based extract formulations.
Join our team and be a part of something exciting.